Who Just RaisedBrooklyn, NY · Health Care · Form D filed Sep 4, 2026
Episteme Prognostics, Inc. raised $5.1M
Episteme Prognostics, Inc. is a biotechnology company based in Brooklyn, New York. In a Form D filed with the SEC on September 4, 2026, it reported raising $5,091,997 from 22 investors as part of an offering of up to $6,017,000. The first sale in the offering took place on August 20, 2026.
- 4th Form D since 2022. Earlier new notices: Mar 10, 2025 · Apr 14, 2023 · Jan 3, 2022. All filings on EDGAR
- Still raising. $925K of the $6M offering was still unsold at filing.
$9.8M raised since 2020
4 Form D offerings, as reported to the SEC, the first in Jan 3, 2022. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 4, 2026 | $5.1M | $6M | 14 |
| Mar 10, 2025 | $550K | $2.5M | 1 |
| Apr 14, 2023 | $4.1M | $4.1M | 16 |
| Jan 3, 2022 | $80K | $3M | 5 |
Lead score
22 out of 100
still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $5,091,997
- Offering size
- $6,017,000
- Investors so far
- 22
- First sale
- August 20, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Brooklyn, New York
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $5,091,997 | $6,017,000 | 22 | SEC filing | |
| D/A (amendment) | $5,091,997 | $6,017,000 | 14 | SEC filing |
Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 31, 2026 · Health Care funding in New York · September 2026 funding report
Similar raises
Lightning Society LLC
Brooklyn, NY · filed Oct 15
Where curiosity meets culture
3rd Form D since 2024
Longplay Media Inc.
Brooklyn, NY · filed Oct 15First Form DStill raising
Get Vocal, PBC
Brooklyn, NY · filed Oct 143rd Form D since 2022
Frictionworx Inc.
Brooklyn, NY · filed Oct 13First Form DStill raising
Hypercell Technologies Inc.
Ithaca, NY · filed Oct 142nd Form D since 2021Still raising
Atmos Clinic, Inc.
New York, NY · filed Oct 8
Affordable healthcare for working people. You set a monthly allowance, your team picks the care they need, and Atmos handles the paperwork and the IRS.
First Form DStill raising
PreciseDx, Inc.
New York, NY · filed Oct 7
Current standards of care in oncology can be subjective, leading to a high percentage of tumors receiving intermediate grading. As a result, many patients are forced to anxiously await the results of…
3rd Form D since 2024
CAD Therapeutics, Inc.
New York, NY · filed Oct 2CAD Therapeutics is developing Clonicaine™, an investigational Phase III-candidate program for PTSD focused on the physiological dimension of the condition. Clonicaine™ is not FDA-approved and is not…
First Form DStill raising